Position in CRMD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,260,937
-$165,758 QoQ
Shares Held
415,406
-17.7% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#26
of 194 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $44,247,243 across 48 Biotechnology names. CRMD ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,557 | $11,571,031 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
111,129 | $6,060,975 | |
| 3 | CRMD |
CorMedix Inc.
This page
|
415,406 | $3,260,937 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
30,352 | $2,473,991 | |
| 5 | TLX |
Telix Pharmaceuticals Ltd
|
197,250 | $2,274,292 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,130 | $2,051,494 | |
| 7 | IBRX |
ImmunityBio, Inc.
|
165,954 | $1,452,927 | |
| 8 | AVXL |
Anavex Life Sciences Corp.
|
504,000 | $1,305,360 |
All Filings in CRMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,260,937 | 415,406 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,426,695 | 504,668 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,402,385 | 378,537 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,175,978 | 273,085 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $985,723 | 80,010 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $526,735 | 85,509 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $131,414 | 16,224 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $175,012 | 21,660 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $136,221 | 31,460 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $133,390 | 31,460 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $118,289 | 31,460 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $117,660 | 31,800 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $150,502 | 37,910 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $159,980 | 37,910 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $106,719 | 37,710 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $83,254 | 20,710 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $120,444 | 21,979 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $91,359 | 20,079 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $85,462 | 18,379 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $143,229 | 20,879 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $208,581 | 20,879 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $163,378 | 21,989 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $133,799 | 22,189 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $164,990 | 26,189 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $84,971 | 23,669 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||